Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.

Nakajima S, Uchida H, Suzuki T, Tomita M, Tsunoda K, Kitta M, Takeuchi H, Nomura K, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2007 Aug;27(4):401-3. No abstract available.

PMID:
17632230
2.

A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.

Malm U, Perris C, Rapp W, Wedrén G.

Acta Psychiatr Scand Suppl. 1974;249:94-116. No abstract available.

PMID:
4608506
3.

Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.

Yamada K, Kanba S, Ohnishi K, Ashikari I, Yagi G, Asai M.

Biol Psychiatry. 1997 May 15;41(10):1062-4. No abstract available.

PMID:
9129786
4.

Panic symptoms in schizophrenia: comorbidity and clinical correlates.

Ulas H, Alptekin K, Akdede BB, Tumuklu M, Akvardar Y, Kitis A, Polat S.

Psychiatry Clin Neurosci. 2007 Dec;61(6):678-80.

5.

Effectiveness of nilvadipine in two cases of chronic schizophrenia.

Yamada K, Ashikari I, Onishi K, Kanba S, Yagi G, Asai M.

Psychiatry Clin Neurosci. 1995 Aug;49(4):237-8.

PMID:
9179944
6.

Open clinical trial of carbamazepine in chronic schizophrenic inpatients.

Wetterling T.

Pharmacopsychiatry. 1987 May;20(3):127-30.

PMID:
3299406
7.

Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study.

Csernansky JG, Lombrozo L, Gulevich GD, Hollister LE.

J Clin Psychopharmacol. 1984 Dec;4(6):349-52.

PMID:
6150950
8.
9.

Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.

Marinis TD, Saleem PT, Glue P, Arnoldussen WJ, Teijeiro R, Lex A, Latif MA, Medori R.

Pharmacopsychiatry. 2007 Nov;40(6):257-63.

PMID:
18030649
10.

An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.

Costa J, Khaled E, Sramek J, Bunney W Jr, Potkin SG.

J Clin Psychopharmacol. 1990 Feb;10(1):71-2. No abstract available.

PMID:
2307738
11.

A factor analytic study of the action of some neuroleptics on chronic schizophrenic syndromes.

Perris C, Hållberg B, Malm U, Wedrén G, Espvall M, Rapp W.

Acta Psychiatr Scand Suppl. 1974;249:123-34. No abstract available.

PMID:
4607777
12.

Treating a schizophrenic patient with severe tardive dystonia without antipsychotics.

Suzuki T, Uchida H, Watanabe K, Kashima H.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1141-2. Epub 2007 Apr 5. No abstract available.

PMID:
17481792
13.

Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. doi: 10.1016/j.pnpbp.2007.12.003. Epub 2007 Dec 14.

PMID:
18201810
14.

For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.

Oulis P, Masdrakis VG, Karapoulios E, Karakatsanis NA, Kouzoupis AV, Papadimitriou GN.

Psychiatry Clin Neurosci. 2009 Feb;63(1):122. doi: 10.1111/j.1440-1819.2008.01890.x. No abstract available.

15.

Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.

Chung YC, Lee CR, Park TW, Yang KH, Kim KW.

World J Biol Psychiatry. 2009;10(2):156-62.

PMID:
19514097
16.

The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.

Ritsner MS, Yorkov V, Ratner Y, Soifer P, Gibel A.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1470-7. Epub 2007 Jul 4.

PMID:
17669573
17.

Blink rate and blunted affect among chronic schizophrenic patients.

Kitamura T, Kahn A, Kumar R, Mackintosh JH.

Biol Psychiatry. 1984 Mar;19(3):429-34. No abstract available.

PMID:
6722233
18.

No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.

Silver H, Geraisy N.

Biol Psychiatry. 1995 Sep 15;38(6):413-5. No abstract available.

PMID:
8547463
19.

Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.

Hanus H, Tůtma I, Zapletálek M, Fusek J, Hrdina V.

Homeost Health Dis. 1991;33(5-6):301-4. No abstract available.

PMID:
18265509
20.

Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Pharmacopsychiatry. 2007 Nov;40(6):269-74.

PMID:
18030651

Supplemental Content

Support Center